Cargando…

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

SUMMARY: Osteoporosis causes an elevated fracture risk. We propose the continued use of T-scores as one means for diagnosis but recommend that, alternatively, hip fracture; osteopenia-associated vertebral, proximal humerus, pelvis, or some wrist fractures; or FRAX scores with ≥3 % (hip) or 20 % (maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Siris, E. S., Adler, R., Bilezikian, J., Bolognese, M., Dawson-Hughes, B., Favus, M. J., Harris, S. T., Jan de Beur, S. M., Khosla, S., Lane, N. E., Lindsay, R., Nana, A. D., Orwoll, E. S., Saag, K., Silverman, S., Watts, N. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988515/
https://www.ncbi.nlm.nih.gov/pubmed/24577348
http://dx.doi.org/10.1007/s00198-014-2655-z
_version_ 1782312029345808384
author Siris, E. S.
Adler, R.
Bilezikian, J.
Bolognese, M.
Dawson-Hughes, B.
Favus, M. J.
Harris, S. T.
Jan de Beur, S. M.
Khosla, S.
Lane, N. E.
Lindsay, R.
Nana, A. D.
Orwoll, E. S.
Saag, K.
Silverman, S.
Watts, N. B.
author_facet Siris, E. S.
Adler, R.
Bilezikian, J.
Bolognese, M.
Dawson-Hughes, B.
Favus, M. J.
Harris, S. T.
Jan de Beur, S. M.
Khosla, S.
Lane, N. E.
Lindsay, R.
Nana, A. D.
Orwoll, E. S.
Saag, K.
Silverman, S.
Watts, N. B.
author_sort Siris, E. S.
collection PubMed
description SUMMARY: Osteoporosis causes an elevated fracture risk. We propose the continued use of T-scores as one means for diagnosis but recommend that, alternatively, hip fracture; osteopenia-associated vertebral, proximal humerus, pelvis, or some wrist fractures; or FRAX scores with ≥3 % (hip) or 20 % (major) 10-year fracture risk also confer an osteoporosis diagnosis. INTRODUCTION: Osteoporosis is a common disorder of reduced bone strength that predisposes to an increased risk for fractures in older individuals. In the USA, the standard criterion for the diagnosis of osteoporosis in postmenopausal women and older men is a T-score of ≤ −2.5 at the lumbar spine, femur neck, or total hip by bone mineral density testing. METHODS: Under the direction of the National Bone Health Alliance, 17 clinicians and clinical scientists were appointed to a working group charged to determine the appropriate expansion of the criteria by which osteoporosis can be diagnosed. RESULTS: The group recommends that postmenopausal women and men aged 50 years should be diagnosed with osteoporosis if they have a demonstrable elevated risk for future fractures. This includes having a T-score of less than or equal to −2.5 at the spine or hip as one method for diagnosis but also permits a diagnosis for individuals in this population who have experienced a hip fracture with or without bone mineral density (BMD) testing and for those who have osteopenia by BMD who sustain a vertebral, proximal humeral, pelvic, or, in some cases, distal forearm fracture. Finally, the term osteoporosis should be used to diagnose individuals with an elevated fracture risk based on the World Health Organization Fracture Risk Algorithm, FRAX. CONCLUSIONS: As new ICD-10 codes become available, it is our hope that this new understanding of what osteoporosis represents will allow for an appropriate diagnosis when older individuals are recognized as being at an elevated risk for fracture.
format Online
Article
Text
id pubmed-3988515
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-39885152014-04-23 The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group Siris, E. S. Adler, R. Bilezikian, J. Bolognese, M. Dawson-Hughes, B. Favus, M. J. Harris, S. T. Jan de Beur, S. M. Khosla, S. Lane, N. E. Lindsay, R. Nana, A. D. Orwoll, E. S. Saag, K. Silverman, S. Watts, N. B. Osteoporos Int Position Paper SUMMARY: Osteoporosis causes an elevated fracture risk. We propose the continued use of T-scores as one means for diagnosis but recommend that, alternatively, hip fracture; osteopenia-associated vertebral, proximal humerus, pelvis, or some wrist fractures; or FRAX scores with ≥3 % (hip) or 20 % (major) 10-year fracture risk also confer an osteoporosis diagnosis. INTRODUCTION: Osteoporosis is a common disorder of reduced bone strength that predisposes to an increased risk for fractures in older individuals. In the USA, the standard criterion for the diagnosis of osteoporosis in postmenopausal women and older men is a T-score of ≤ −2.5 at the lumbar spine, femur neck, or total hip by bone mineral density testing. METHODS: Under the direction of the National Bone Health Alliance, 17 clinicians and clinical scientists were appointed to a working group charged to determine the appropriate expansion of the criteria by which osteoporosis can be diagnosed. RESULTS: The group recommends that postmenopausal women and men aged 50 years should be diagnosed with osteoporosis if they have a demonstrable elevated risk for future fractures. This includes having a T-score of less than or equal to −2.5 at the spine or hip as one method for diagnosis but also permits a diagnosis for individuals in this population who have experienced a hip fracture with or without bone mineral density (BMD) testing and for those who have osteopenia by BMD who sustain a vertebral, proximal humeral, pelvic, or, in some cases, distal forearm fracture. Finally, the term osteoporosis should be used to diagnose individuals with an elevated fracture risk based on the World Health Organization Fracture Risk Algorithm, FRAX. CONCLUSIONS: As new ICD-10 codes become available, it is our hope that this new understanding of what osteoporosis represents will allow for an appropriate diagnosis when older individuals are recognized as being at an elevated risk for fracture. Springer London 2014-02-28 2014 /pmc/articles/PMC3988515/ /pubmed/24577348 http://dx.doi.org/10.1007/s00198-014-2655-z Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Position Paper
Siris, E. S.
Adler, R.
Bilezikian, J.
Bolognese, M.
Dawson-Hughes, B.
Favus, M. J.
Harris, S. T.
Jan de Beur, S. M.
Khosla, S.
Lane, N. E.
Lindsay, R.
Nana, A. D.
Orwoll, E. S.
Saag, K.
Silverman, S.
Watts, N. B.
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
title The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
title_full The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
title_fullStr The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
title_full_unstemmed The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
title_short The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
title_sort clinical diagnosis of osteoporosis: a position statement from the national bone health alliance working group
topic Position Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988515/
https://www.ncbi.nlm.nih.gov/pubmed/24577348
http://dx.doi.org/10.1007/s00198-014-2655-z
work_keys_str_mv AT sirises theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT adlerr theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT bilezikianj theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT bolognesem theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT dawsonhughesb theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT favusmj theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT harrisst theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT jandebeursm theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT khoslas theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT lanene theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT lindsayr theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT nanaad theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT orwolles theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT saagk theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT silvermans theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT wattsnb theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT sirises clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT adlerr clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT bilezikianj clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT bolognesem clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT dawsonhughesb clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT favusmj clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT harrisst clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT jandebeursm clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT khoslas clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT lanene clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT lindsayr clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT nanaad clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT orwolles clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT saagk clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT silvermans clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup
AT wattsnb clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup